Text Message Program Could Curb Tobacco Use

Share this content:
Text Message Program Could Curb Tobacco Use
Text Message Program Could Curb Tobacco Use

(HealthDay News) -- An automated, personalized, and interactive mobile health program, Text2Quit, seems to be effective for promoting smoking cessation, according to a study published online in the American Journal of Preventive Medicine.

Lorien C. Abroms, ScD, from The George Washington University School of Public Health and Health Services in Washington, D.C., and colleagues examined the impact of Text2Quit on biochemically-confirmed repeated point prevalence abstinence.

RELATED: Lung Cancer Resource Center

Five hundred three participants were recruited on the Internet and randomly assigned to the Text2Quit program or to receive self-help material. Smoking status was assessed using participant surveys conducted at baseline and at 1, 3, and 6 months post-enrollment.

The researchers found that biochemically-confirmed repeated point prevalence abstinence was seen in 11.1% of the intervention group and 5.0% of the control group (relative risk, 2.22; P < 0.05). Self-reported repeated point prevalence abstinence was also higher in the intervention versus the control group (19.9% vs. 10.0%; P < 0.01).

Across demographic subgroups analyzed, the effects were uniform, although the effect was suggested to be larger for non-whites than whites.

"The results provide initial support for the relative efficacy of the Text2Quit program," the researchers wrote.

The Test2Quit Program has been licensed to Voxiva Inc.; one author disclosed financial ties to Voxiva.

Reference

  1. Abroms LC, Boal AL, Simmens SJ et al. A Randomized Trial of Text2Quit: A Text Messaging Program for Smoking Cessation. Am J Prev Med. 2014;doi:10.1016/j.amepre.2014.04.010.

Related Resources

Related Slideshows

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs